Search

Search Constraints

You searched for: Author/Creator Enblad, G.

Search Results

1. A PHASE 1/2 STUDY OF PIXANTRONE, ETOPOSIDE, BENDAMUSTINE AND, IN CD20+ TUMORS, RITUXIMAB IN PATIENTS WITH RELAPSED AGGRESSIVE B‐ OR T‐CELL LYMPHOMAS—THE P[R]EBEN STUDY. (June 2017)

2. APPLICATION OF a GENE EXPRESSION‐BASED MODEL IN COMBINATION WITH FDG‐PET IMAGING TO PREDICT TREATMENT RESPONSE IN ADVANCED HODGKIN LYMPHOMA IN THE RATHL STUDY (CRUK/07/033). (June 2017)

4. FOCAL SKELETAL 18F‐FDG UPTAKE CHARACTERIZES A SUBSET OF CLASSICAL HODGKIN LYMPHOMA PATIENTS WITH POOR OUTCOME—A DANISH‐SWEDISH STUDY OF 209 NEWLY DIAGNOSED PATIENTS. (June 2017)

6. OUTCOMES OF TREATMENT FOR OBESE PATIENTS WITH ADVANCED HODGKIN LYMPHOMA IN THE RATHL TRIAL (CRUK/07/033). (June 2017)

7. Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B‐cell lymphoma patients with and without rheumatic disease. (29th May 2015)

8. RESPONSE‐ADJUSTED THERAPY FOR ADVANCED HODGKIN LYMPHOMA (RATHL) TRIAL: LONGER FOLLOW UP CONFIRMS EFFICACY OF DE‐ESCALATION AFTER a NEGATIVE INTERIM PET SCAN (CRUK/07/033). (June 2017)